chr16-1220242-ATCACCAGCTCCGCCT-A

Position:

• chr16-1220242-ATCACCAGCTCCGCCT-A

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM4 BS1_Supporting BS2

The NM_021098.3(CACNA1H):​c.6311_6325delTCACCAGCTCCGCCT​(p.Ile2104_Cys2109delinsSer) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0000379 in 1,584,744 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

• Frequency:
  • Genomes: 𝑓 0.00024 (0 hom., cov: 35)
  • Exomes 𝑓: 0.000017 (0 hom.)
• Consequence: CACNA1H NM_021098.3 disruptive_inframe_deletion
• Clinical Significance: Uncertain significance criteria provided, multiple submitters, no conflicts U:2
• Conservation: PhyloP100: 4.81

Genes affected

CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

CACNA1H (HGNC:):

ACMG classification

Verdict is Likely_benign. Variant got -3 ACMG points.

• PM4: Nonframeshift variant in NON repetitive region in NM_021098.3.
• BS1: Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000237 (36/152086) while in subpopulation AMR AF= 0.00216 (33/15284). AF 95% confidence interval is 0.00158. There are 0 homozygotes in gnomad4. There are 29 alleles in male gnomad4 subpopulation. Median coverage is 35. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
• BS2: High AC in GnomAd4 at 36 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
CACNA1H	NM_021098.3	c.6311_6325delTCACCAGCTCCGCCT	p.Ile2104_Cys2109delinsSer	disruptive_inframe_deletion	35/35	ENST00000348261.11	NP_066921.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
CACNA1H	ENST00000348261.11	c.6311_6325delTCACCAGCTCCGCCT	p.Ile2104_Cys2109delinsSer	disruptive_inframe_deletion	35/35	1	NM_021098.3	ENSP00000334198.7
CACNA1H	ENST00000565831.6	c.6293_6307delTCACCAGCTCCGCCT	p.Ile2098_Cys2103delinsSer	disruptive_inframe_deletion	33/33	1		ENSP00000455840.1
CACNA1H	ENST00000638323.1	c.6272_6286delTCACCAGCTCCGCCT	p.Ile2091_Cys2096delinsSer	disruptive_inframe_deletion	35/35	5		ENSP00000492267.1
CACNA1H	ENST00000569107.5	c.2549_2563delTCACCAGCTCCGCCT	p.Ile850_Cys855delinsSer	disruptive_inframe_deletion	17/17	1		ENSP00000454990.2
CACNA1H	ENST00000564231.5	c.2501_2515delTCACCAGCTCCGCCT	p.Ile834_Cys839delinsSer	disruptive_inframe_deletion	18/18	1		ENSP00000457555.2
CACNA1H	ENST00000562079.5	c.2483_2497delTCACCAGCTCCGCCT	p.Ile828_Cys833delinsSer	disruptive_inframe_deletion	17/17	1		ENSP00000454581.2
CACNA1H	ENST00000639478.1	n.*1359_*1373delTCACCAGCTCCGCCT		non_coding_transcript_exon_variant	35/35	5		ENSP00000491945.1
CACNA1H	ENST00000640028.1	n.*4129_*4143delTCACCAGCTCCGCCT		non_coding_transcript_exon_variant	35/35	5		ENSP00000491488.1
CACNA1H	ENST00000639478.1	n.*1359_*1373delTCACCAGCTCCGCCT		3_prime_UTR_variant	35/35	5		ENSP00000491945.1
CACNA1H	ENST00000640028.1	n.*4129_*4143delTCACCAGCTCCGCCT		3_prime_UTR_variant	35/35	5		ENSP00000491488.1

Frequencies

GnomAD3 genomes AF: 0.000237 AC: 36 AN: 152086 Hom.: 0 Cov.: 35

Gnomad AFR AF: 0.00

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00216

Gnomad ASJ AF: 0.00

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.00

Gnomad NFE AF: 0.00

Gnomad OTH AF: 0.00143

GnomAD3 exomes AF: 0.0000333 AC: 7 AN: 210298 Hom.: 0 AF XY: 0.0000254 AC XY: 3 AN XY: 118244

Gnomad AFR exome AF: 0.00

Gnomad AMR exome AF: 0.000154

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.00

Gnomad SAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.0000208

Gnomad OTH exome AF: 0.00

GnomAD4 exome AF: 0.0000168 AC: 24 AN: 1432658 Hom.: 0 AF XY: 0.0000140 AC XY: 10 AN XY: 712442

Gnomad4 AFR exome AF: 0.00

Gnomad4 AMR exome AF: 0.000279

Gnomad4 ASJ exome AF: 0.00

Gnomad4 EAS exome AF: 0.00

Gnomad4 SAS exome AF: 0.00

Gnomad4 FIN exome AF: 0.00

Gnomad4 NFE exome AF: 0.00000453

Gnomad4 OTH exome AF: 0.000118

GnomAD4 genome AF: 0.000237 AC: 36 AN: 152086 Hom.: 0 Cov.: 35 AF XY: 0.000390 AC XY: 29 AN XY: 74296

Gnomad4 AFR AF: 0.00

Gnomad4 AMR AF: 0.00216

Gnomad4 ASJ AF: 0.00

Gnomad4 EAS AF: 0.00

Gnomad4 SAS AF: 0.00

Gnomad4 FIN AF: 0.00

Gnomad4 NFE AF: 0.00

Gnomad4 OTH AF: 0.00143

Alfa AF: 0.0000434 Hom.: 0

Bravo AF: 0.000204

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

Labcorp Genetics (formerly Invitae), Labcorp

Jan 14, 2024

This variant, c.6311_6325del, is a complex sequence change that results in the deletion of 6 and insertion of 1 amino acid(s) in the CACNA1H protein (p.Ile2104_Cys2109delinsSer). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. ClinVar contains an entry for this variant (Variation ID: 529561). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

GeneDx

May 28, 2024

In-frame deletion of 6 amino acids and in-frame insertion of 1 amino acid in a non-repeat region; In silico analysis indicates that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs774660673; hg19: chr16-1270242;